PTGDS and asthma: PGE2 signaling through its EP2 receptor blocks mast cell degranulation, limits eosinophil migration, and inhibits the allergen-stimulated release of mast cell-derived inflammatory mediators including PGD2 in the airways of asthma patients, providing another possible mechanism for its bronchoprotective action (99, 100).